⟵ Back to Search Results

BGB-3111_BGB-A317_Study_001

Completed

Zanubrutinib (BGB-3111) in Combination With Tislelizumab (BGB-A317) in Participants With B-cell Malignancies

Beigene Study ID info

BGB-3111_BGB-A317_Study_001

ClinicalTrials.gov ID info

NCT02795182

China Drug Trials ID info

CTR20180193

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)

No Study Documents

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)

No Study Documents